Overweight
Studies have shown that the substances in the samples are promising for weight loss among people worldwide
Research
Quality product samples tested and proven
Type 2 diabetes
Medical breakthrough
What is GLP-1+GIP?
GLP-1+GIP is a formulation that represents a new class of products used in the treatment of diabetes and the fight against obesity. It is a single peptide that activates two incretin hormones in the body - the GLP-1, which is a hormone secreted by the gut in response to food intake and GIP, its main role focuses on stimulating insulin secretion. More importantly, GIP has the ability to improve fat metabolism, affecting fat storage and burning. These are naturally released through the intestines. This action firstly regulates blood glucose levels and secondly controls appetite. After eating a meal, we quickly feel satiety, but more importantly, our blood sugar levels do not rise sharply. The peptide is more effective at regulating glucose levels than other treatments currently in use. It can also be helpful to people suffering from obesity or struggling with excess weight, so it is readily used for weight loss. In fact, the product is gaining more popularity.
Thirzepatide is administered only once a week. It activates the pathways GLP-1+GIP, which leads to reduce the amount of food consumed, and increase energy expenditure, resulting in a large reduction in body weight. GLP-1 and GIP pathways odelay gastric emptying and stimulate the sensation of satiety in the hypothalamus, so the feeling of hunger is strongly inhibited. Importantly, the person using the peptide not only feels less hunger, but is able to better control his diet. This action will primarily promote weight loss, maintaining a diet, but also controlling cravings for sweets, for example.
A study conducted by American researchers shows that thirzepatide can reduce as much as 20-25% of total body weight for people who have problems with overweight and obesity.
Examples of reagents available on the market:
All Ready Designs Pro
Get unlimited access to all current and upcoming designs when using Rife Pro Theme. See them all!
Revolution Slider Pro
Responsive WordPress Slider Plugin that displays your content in a beautiful way included for free!
Premium Support Pro
Whenever you struggle with anything regarding Rife Pro, just hit us with a message on our support forum.
Peptide glp-1+gip 2.5 mg
Thirzepatide is a peptide that has already helped many people achieve a slim and shapely figure. A 2.5 mg pack is enough for you for 1 or 2 weeks of full initial treatment, which will allow you to get acquainted with the powerful effects of the preparation!
First of all, the peptide's effectiveness is due to its effect on GLP-1 and GIP receptors. Their action has a significant effect on regulating blood sugar levels, as well as having a number of other properties that will help you lose weight. Thiopeptide makes you able to take control of your appetite. The peptide makes you stop feeling strong hunger and significantly reduce the amount of food you eat. You also stop snacking and craving sweet things, which translates into better diet control!
The action of the peptide significantly reduces the time it takes to achieve a slim figure!
There are many studies on the efficacy of the peptide, and most of them talk about the potential benefit of 20-25% weight loss. Depending on your starting weight, you are able to lose 15 to 25 pounds!
All descriptions are based on : scientific sources. They are for informational purposes only.
Peptide glp-1+gip 5 mg
This is a revolutionary solution for people who want to achieve a slim figure. Thirzepatide with a concentration of 5 mg is most often chosen by our customers, as this amount is enough for a full 2 or 4 weeks of initial treatment!
The peptide works by activating two receptors - GLP-1 and GIP. These are hormones that are crucial for regulating sugar levels in the body, but also not only. The action of the peptide makes you stop feeling hungry! Sticking to dietary guidelines thus becomes very easy. No craving for sweets, smaller food portions, longer feeling of satiety will effectively make your weight loss more effective.
If you are looking to get quick results, this is the solution for you.
Studies have shown that with the use of thiothromatide, it becomes possible to achieve impressive results - up to 20-25% reduction in total body weight. This means that A person weighing 80 kilograms is able to realistically gain a body weight of 60 kilograms! The action of the peptide is very effective.
All descriptions are based on : scientific sources. They are for informational purposes only.
Peptide glp-1+gip 5 mg
Great product, for those who want to get rid of excess weight. Thirzepatide Pen with a concentration of 5 mg is a great and easy way to uncontrollable appetite and reduce body fat.
The product patterns itself after the two receptors GLP-1 and GIP. The dual potency makes our product in Pena very good at dealing with the urge to eat and perpetual appetite. The peptide suppresses appetite, increases the sensation of satiety in the stomach, and blocks the appetite for sweets. As a result, we don't crave food, which is so addictive and harmful. In addition, the product makes us feel full and satiated for longer, and as a result, we eat less often and less.
If you are looking for a way to lose weight and body fat quickly, this product is for you.
In addition, during the one-year follow-up, doctors noted that thiothiazepatide pen caused a reduction in fat in the liver from 27% to 3%.
This fact tells us that thirzepatide not only promotes in the fight against obesity, but also shows health-promoting effects.
All descriptions are based on : scientific sources. They are for informational purposes only.
Effects of use
OF A STUDY INVOLVING 2,500 PEOPLE (WHO DID NOT HAVE TYPE 1 DIABETES) SHOWED THAT MORE THAN 60 PERCENT OF OF OBESE OR OVERWEIGHT PATIENTS WHO TOOK A DOSE OF BETWEEN 5-15 MG OF THIOTHIAZIDE FOR MORE THAN A YEAR SUCCEEDED IN REDUCING AT LEAST 20 PERCENT. OF THEIR TOTAL BODY WEIGHT. SOME OF THEM LOST AS MUCH AS 22.5 - 25 PERCENT. (MAXIMUM 28 KG). AS WE CAN SEE, THESE COUNTS SPEAK FOR THEMSELVES, AND THE EFFECTIVENESS OF THE PEPTIDE IS UNDENIABLE. BUT MORE IMPORTANTLY, USE OF THE MEDICINE IS FREE. ALL YOU NEED TO DO IS TO TAKE THE RIGHT DOSE ONCE A WEEK, WHICH WILL ALLOW YOU TO ENJOY EXCELLENT RESULTS. ARE YOU READY TO FINALLY ENJOY A SLIM APPEARANCE?
How does glp-1+gip work?
Thirzepatide is a unique peptide that mimics the functions of incretins - are hormones that are naturally produced in our body after eating a meal. This special peptide binds to receptors that target two important hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This action causes, firstly, the pancreas to be stimulated to produce insulin, and secondly, the feeling of satiety is increased.
What makes tirzepatide so unique? Above all, action on GLP-1+GIP. They stimulate the pancreas to secrete insulin, in response to food consumption, but only when necessary, that is, when sugar levels are too high. In this way, it does not cause dangerous drops in blood sugar, but most importantly, you do not feel fluctuations in blood glucose levels and hunger.
But these are not all the benefits experienced after using the peptide. Also, it enhances the feeling of satiety, suppressing excessive appetite, which is beneficial not only for people with diabetes, but also for those with normal sugar levels. Not once have you found yourself waking up in the middle of the night to empty the refrigerator? From now on you can forget about it! Thirzepatide will allow you to fully control your appetite, and most importantly, your health and appearance will improve significantly.
See for yourself how thiothiazepatide can revolutionize your health as well as your well-being. If you have questions, write to us to learn more about this breakthrough peptide.
Scientific studies unequivocally confirm that a weekly dose of the formula, approved by the renowned US Food and Drug Administration, significantly facilitates the fight against obesity and overweight. Moreover, the valuable data show that healthy individuals can lose up to 25% of their initial weight, making the results achievable comparable to surgical obesity treatments.
The results of the study, which included as many as 2,500 participants without type 1 diabetes, are extremely promising. Some 60% of obese or overweight patients who took a dose of 5 to 15 mg for more than a year managed to reduce at least 20% of their total body weight. Some have recorded an impressive drop of as much as 22.5-25% (which is up to 28 kg). But more importantly, the weight loss achieved in this trial surpassed the results of previous studies conducted on people with diabetes, making it possible to conclude that tirzepatide has a strong weight-loss effect.
The sensational findings were presented by Dr. Robert Gabbay, medical director of the American Diabetes Association, during an interview with CNN. In the interview he said: "This is a momentous discovery that certainly deserves attention and opens new perspectives in the treatment of overweight and obesity, so we can improve the health and comfort of many patients' lives.". But more importantly, these people achieved excellent results without major changes in diet or additional training, making weight loss effortless.
glp-1+gip or glp-1 alone?
Thirzepatide is a newer generation of semaglutide. First, it is a newer formulation, and secondly, it has fewer side effects, but it is also more effective. Thirzepatide is more effective in regulating blood sugar levels. It lowers blood glucose levels in two different ways, compared to Semaglutide, which acts on a single receptor. In addition, thirzepatide is available in a wider range of doses compared to Semaglutide, so we can adjust the dosage individually. Thirzepatide is currently the only product in its class known as a dual glucagon-like peptide 1 (GLP-1) glucose-dependent peptide (GIP) receptor agonist, making it the best option for anti-obesity therapy. Thirzepatide works in two different ways - first, it activates GLP-1 receptors, and second, it also activates GIP pathways, so we have the ability to act even more potently on the body. Semaglutide belongs to a class of drugs that are GLP-1 receptor-only agonists, so it works similarly to Thirzepatide without activating GIP pathways.
All descriptions are based on scientific sources. They are for informational purposes only.
Satisfied customers
change your habits
online technical support
laboratory-tested products
service in 10 countries around the world
Start your transformation
Contact us
All the properties mentioned above were observed with laboratory tests. They are for informational purposes only. Any information contained in the descriptions is not approved by GIS, GIF or EFSA. The substance is not a drug, food product or dietary supplement and is not suitable for human consumption. The product is qualified as a chemical reagent / reference material approved for marketing in the EU. It can only be used for scientific research. Other information about the agent is contained in the Material Safety Data Sheet, which is available for review. Products are available to institutions or individuals who are associated with research or laboratory activities.